Jazz Pharmaceuticals plc today announced that the U.S. Food and Drug Administration approved the intravenous administration of Erwinaze (asparaginase Erwinia chrysanthemi).

View the original here:
FDA approves intravenous administration of Erwinaze (asparaginase Erwinia chrysanthemi)